Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

New imaging AI tool hits market with reimbursement eligibility
The product, which is offered within Elucid’s novel Plaque-IQ software suite, allows physicians to analyze lesion composition and plaque burden across any vessel.
FDA links weight loss pill to ‘unexpected’ cardiovascular risks
The once-daily pill received FDA approval on April 1. However, the agency has requested additional data on multiple potential side effects.
ACIP panel given new guidance to shape vaccine recommendations
The shift comes after a federal court struck down sweeping changes to the pediatric vaccine schedule that went into effect in 2026. The committee of medical experts, which advises on policy at the Centers for Disease Control and Prevention (CDC), will have to focus on a cost-benefit analysis in its future analyses.
Supporters vs. denouncers of the White House’s proposed 2027 budget: Voices heard in or near healthcare circles
If the budget makes it through Congress intact as submitted—a big if even with the president’s party in the majority in both chambers—healthcare is in for some strict belt-tightening.
Rural hospital CEO talks Medicaid cuts, staffing challenges and the joys of community healthcare delivery
An exclusive interview with Scott Steiner, CEO of Phoebe Putney—a nonprofit health system that serves Southwest Georgia.

Elucid's new Lesion Analysis Tool now commercially available

New imaging AI tool hits market with reimbursement eligibility

The product, which is offered within Elucid’s novel Plaque-IQ software suite, allows physicians to analyze lesion composition and plaque burden across any vessel.

overweight patient seeking health advice

FDA links weight loss pill to ‘unexpected’ cardiovascular risks

The once-daily pill received FDA approval on April 1. However, the agency has requested additional data on multiple potential side effects.

ACIP panel given new guidance to shape vaccine recommendations

The shift comes after a federal court struck down sweeping changes to the pediatric vaccine schedule that went into effect in 2026. The committee of medical experts, which advises on policy at the Centers for Disease Control and Prevention (CDC), will have to focus on a cost-benefit analysis in its future analyses.

Supporters vs. denouncers of the White House’s proposed 2027 budget: Voices heard in or near healthcare circles

If the budget makes it through Congress intact as submitted—a big if even with the president’s party in the majority in both chambers—healthcare is in for some strict belt-tightening.

Rural hospital CEO talks Medicaid cuts, staffing challenges and the joys of community healthcare delivery

An exclusive interview with Scott Steiner, CEO of Phoebe Putney—a nonprofit health system that serves Southwest Georgia.

Facility puts mammo services on hold after audit uncovers 'serious' image quality concerns

Women who underwent mammograms at the facility during the specified timeframe may need to have those exams repeated.

Darryl Drevna, senior director of regulatory affairs, American Medical Group Association (AMGA), explains why the group objects to a near-complete freeze in an annual payment adjustment for Medicare Advantage (MA) plans, arguing it fails to keep pace with the real-world costs of delivering care to Medicare patients.

AMGA pushes back on Medicare Advantage payment adjustment and outlines needed reforms

The American Medical Group Association explains why it has issues with the payment adjustment for Medicare Advantage plans, arguing it fails to keep pace with the real-world costs.

FDA shares warning about cath lab procedure kits due to risk of patient injury

The syringes included in several convenience kits should not be used due to a safety risk linked to multiple injuries.